Logo image of MAXN

MAXEON SOLAR TECHNOLOGIE (MAXN) Stock Fundamental Analysis

NASDAQ:MAXN - Nasdaq - SGXZ57724486 - Common Stock - Currency: USD

5.22  -0.29 (-5.26%)

After market: 5.25 +0.03 (+0.57%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MAXN. MAXN was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN has a bad profitability rating. Also its financial health evaluation is rather negative. MAXN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
MAXN had a negative operating cash flow in the past year.
MAXN had negative earnings in each of the past 5 years.
MAXN had negative operating cash flow in 4 of the past 5 years.
MAXN Yearly Net Income VS EBIT VS OCF VS FCFMAXN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of MAXN (-175.55%) is worse than 95.37% of its industry peers.
Industry RankSector Rank
ROA -175.55%
ROE N/A
ROIC N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAXN Yearly ROA, ROE, ROICMAXN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5K 10K 15K 20K

1.3 Margins

MAXN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAXN Yearly Profit, Operating, Gross MarginsMAXN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MAXN has been reduced compared to 1 year ago.
Compared to 5 years ago, MAXN has less shares outstanding
Compared to 1 year ago, MAXN has a worse debt to assets ratio.
MAXN Yearly Shares OutstandingMAXN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAXN Yearly Total Debt VS Total AssetsMAXN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

MAXN has an Altman-Z score of -5.68. This is a bad value and indicates that MAXN is not financially healthy and even has some risk of bankruptcy.
MAXN's Altman-Z score of -5.68 is on the low side compared to the rest of the industry. MAXN is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.68
ROIC/WACCN/A
WACC7.42%
MAXN Yearly LT Debt VS Equity VS FCFMAXN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.11 indicates that MAXN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.11, MAXN is doing worse than 88.89% of the companies in the same industry.
MAXN has a Quick Ratio of 1.11. This is a bad value and indicates that MAXN is not financially healthy enough and could expect problems in meeting its short term obligations.
MAXN's Quick ratio of 0.48 is on the low side compared to the rest of the industry. MAXN is outperformed by 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.48
MAXN Yearly Current Assets VS Current LiabilitesMAXN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for MAXN have decreased strongly by -16053.04% in the last year.
The Revenue for MAXN has decreased by -28.03% in the past year. This is quite bad
Measured over the past years, MAXN shows a small growth in Revenue. The Revenue has been growing by 4.25% on average per year.
EPS 1Y (TTM)-16053.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.79%
Revenue 1Y (TTM)-28.03%
Revenue growth 3Y9.96%
Revenue growth 5Y4.25%
Sales Q2Q%-61.09%

3.2 Future

The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
Based on estimates for the next years, MAXN will show a decrease in Revenue. The Revenue will decrease by -2.18% on average per year.
EPS Next Y99.96%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-42.95%
Revenue Next 2Y-12.34%
Revenue Next 3Y-2.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MAXN Yearly Revenue VS EstimatesMAXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MAXN Yearly EPS VS EstimatesMAXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MAXN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MAXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAXN Price Earnings VS Forward Price EarningsMAXN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAXN Per share dataMAXN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400

4.3 Compensation for Growth

A more expensive valuation may be justified as MAXN's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAXN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (2/21/2025, 8:00:01 PM)

After market: 5.25 +0.03 (+0.57%)

5.22

-0.29 (-5.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners5.45%
Inst Owner Change-100%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap79.45M
Analysts45
Price Target57.25 (996.74%)
Short Float %14.9%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.95%
Min EPS beat(2)-12.21%
Max EPS beat(2)82.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.76%
Min Revenue beat(2)-15.54%
Max Revenue beat(2)2.03%
Revenue beat(4)1
Avg Revenue beat(4)-5.9%
Min Revenue beat(4)-15.54%
Max Revenue beat(4)2.03%
Revenue beat(8)2
Avg Revenue beat(8)-4.76%
Revenue beat(12)4
Avg Revenue beat(12)-2.93%
Revenue beat(16)5
Avg Revenue beat(16)-2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-42.94%
EPS NQ rev (3m)-9023.87%
EPS NY rev (1m)99.61%
EPS NY rev (3m)98.83%
Revenue NQ rev (1m)47.3%
Revenue NQ rev (3m)20.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-598.1
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-26.23
FCFYN/A
OCF(TTM)-22.31
OCFYN/A
SpS57.59
BVpS-13.87
TBVpS-13.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -175.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.75%
Cap/Sales 6.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.48
Altman-Z -5.68
F-Score2
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)199.78%
Cap/Depr(5y)147.34%
Cap/Sales(3y)10.57%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16053.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.79%
EPS Next Y99.96%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-28.03%
Revenue growth 3Y9.96%
Revenue growth 5Y4.25%
Sales Q2Q%-61.09%
Revenue Next Year-42.95%
Revenue Next 2Y-12.34%
Revenue Next 3Y-2.18%
Revenue Next 5YN/A
EBIT growth 1Y-1190.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.49%
EBIT Next 3Y35.95%
EBIT Next 5YN/A
FCF growth 1Y-275.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2575.5%
OCF growth 3YN/A
OCF growth 5YN/A